Skip to content

Virginia · Nonprofit

AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES FOUNDATION

AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES FOUNDATION (Virginia) receives grants from 14 organizations whose IRS filings report $1,112,497 to it, the largest being FIDELITY INVESTMENTS CHARITABLE GIFT FUND ($631,712). 5 of them have funded it in more than one year, and 72% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.

Revenue FY2025
$4.7M
Funders on record
14
Grants received
$1.1M
Net assets
$39M
5/14 repeat funderspeak grant-dependency 10%
01What it does

What American Association for the Study of Liver Diseases Foundation does

Mission

To invest in innovative hepatology research and in the people who study and treat liver disease.

As stated on its FY2025 Form 990.

Programs

  1. Grants and awardsthe aasld foundation raises funds to support the next generation of reesarchers and clinicial expertise in the field of hepatology. Specifically, the foundation focuses on programs that provide funding to support careers in basic and clinical research, workforce development programs and opportunities for early-career professionals to engage with the community:1. Research grants: funding institutions to advance liver disease research.2. Clinical training awards: supporting advanced training for hepatology fellows, nurse practitioners, and physician assistants.3. Workforce development programs: programs developed to support and mentor those pursuing careers in hepatology research and clinical practice. 4. Abstract awards: enabling early career investigators to present promising research at premier hepatology scientific meetings, fostering the next generation of leaders.

    $2,018,819 spentof which $1,581,555 as grants
    80% of program spending
  2. Liver leader councilthe liver leader council (llc) is a dynamic corporate partnership program that engages industry leaders through exclusive benefits, discounts, and strategic summits. Held biannually in conjunction with digestive disease week and the liver meeting, llc summits unite industry, member-experts, regulators, and patient advocates to address emerging challenges and opportunities in liver disease, fostering collaboration and innovation.

    $273,227 spent
    11% of program spending
  3. Emerging liver scholarsthe emerging liver scholars (els) program, a joint initiative with aasld, inspires medical, surgical, and pediatric residents with potential for academic medicine to pursue hepatology. By providing mentorship and exposure to cutting-edge research, the els program invests in the future of hepatology, cultivating passionate and skilled professionals.

    $133,579 spent
    5% of program spending
  4. Public awarenessthe aasld foundation raises awareness of liver disease through its website and by exhibiting at key meetings and conventions. By distributing educational resources, the foundation empowers the public and professionals to better understand and address liver health challenges.

    $104,737 spent
    4% of program spending

The 4 programs described on its FY2024 Form 990, listed largest first by expense. Program spending in total: $2,530,362.

02The organization over time

The organization over time

Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.

100 = 20172017 Revenue 100 ($5.1M) Expenses 100 ($4.6M) Net assets 100 ($13M)2018 Revenue 78 ($4.0M) Expenses 133 ($6.1M) Net assets 87 ($11M)2019 Revenue 141 ($7.2M) Expenses 126 ($5.7M) Net assets 101 ($13M)2020 Revenue 83 ($4.2M) Expenses 84 ($3.9M) Net assets 104 ($14M)2021 Revenue 60 ($3.0M) Expenses 84 ($3.8M) Net assets 119 ($16M)2022 Revenue 26 ($1.3M) Expenses 51 ($2.3M) Net assets 99 ($13M)2023 Revenue 71 ($3.6M) Expenses 72 ($3.3M) Net assets 108 ($14M)2024 Revenue 479 ($24M) Expenses 89 ($4.1M) Net assets 274 ($36M)2025 Revenue 92 ($4.7M) Expenses 73 ($3.4M) Net assets 295 ($39M)
'17'18'19'20'21'22'23'24'25
Revenue (92)Expenses (73)Net assets (295)Peer revenue range

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2023 to 2024, from $17M to $40M (+132%).

$17M
$17M
$19M
$18M
$20M
$16M
$17M
$40M
$42M
'17'18'19'20'21'22'23'24'25
Total assetsTotal liabilities

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2017
2018
2019
2020
2021
2022
2023
2024
2025
ContributionsProgram revenueInvestmentOther

86% of AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES FOUNDATION’s revenue is contributions — more donation-reliant than the typical peer (51% for the typical peer).

This organization
Typical peer · 8,611 orgs

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 3 of the last 9 reported years ran a deficit.

$504k
’17
−$2.1M
’18
$1.4M
’19
$346k
’20
−$797k
’21
−$1.0M
’22
$302k
’23
$20M
’24
$1.3M
’25
4.9
months of
reserve

Leadership and staff

The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.

Board chair

Kimberly Ann Brown

Chair

As listed on its FY2025 Form 990.

'17'18'19'20'21'22'23'24'25
Listed101110121010101311
Joined·+3+2+3+3+2+2+3+3
No longer listed·23152205
03Who funds it

Who funds it, year by year

2017 → 2023: the base broadened from 2 funders to 5 funders, grant income rose $6k → $206k.

8 of 14 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 72% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.

Left out of every figure on this page: $9.1M from one payer (the payer shares this organization's board, largest American Association for the Study of Liver Diseases). These are real filings, and they are not money AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES FOUNDATION raised.

From the IRS filings of AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES FOUNDATION’s funders (the co-funder graph). Top 13 of 14 funders by total. Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How concentrated its funding is

AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES FOUNDATION leans on a few funders — its largest provides 57% of grant income and the top three 79%; half comes from just 1 funder.

the vertical line marks half of all grant income — 1 funder to its left

79% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES FOUNDATION.

57%
largest funder
79%
top three
~3
effective funders

Largest funder’s share by year: 2017 90% · 2018 50% · 2019 49% · 2020 67% · 2021 85% · 2022 53% · 2023 51% — diversifying over time.

“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How long its funders stay

40% of AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES FOUNDATION's funders are still giving 3 years after their first grant; 36% give in more than one year at all.

first grant+1y+2y+3y+4y+5y

Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.

Where its funders are

72% of AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES FOUNDATION's grant income arrives through donor-advised or pass-through sponsors, whose addresses record where the money is held rather than where the donor is. Of the $312k that is directly attributable, 100% of it comes from funders outside Virginia, across 5 states.

IL
MA
CT
KY
DC

In-state vs out-of-state, by year

’17
’18
’19
’20
’23
Virginia out of state home

Funder states come from each funder’s own filing. $801k arriving through sponsors registered in 6 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

04Its place in the field

Against its field

AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES FOUNDATION runs a healthier operating margin than three-quarters of the 4,665 health nonprofits its size.

Operating margin28% · top quartile
Months of reserve4.9mo · above the median
Revenue growth (annualized)−1% · bottom quartile

this organization peer median middle 50% of peers· 4,665 health nonprofits $1M–$10M, FY2025

Organizations like AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES FOUNDATION

Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.

In Virginia

Nationally

05Profile & governance

Read directly from this organization’s own Form 990, as neutral context.

Where the money goes

75% of spending goes to programs.

Program 75%Management 16%Fundraising 9%

Governance

7
board members
100%
independent
✓Conflict-of-interest policy✓Whistleblower policy✓Document retention✓Board reviewed the 990✓Audited financials

Public support

46%

Share of support from the public (Schedule A) — the basis for its public-charity status.

Footprint & structure

Files a return copy in 29 states

NH
MN
IL
WI
MI
NY
MA
OR
PA
NJ
CT
RI
CA
UT
KY
WV
VA
MD
NM
KS
AR
TN
NC
SC
HI
MS
AL
GA
FL

Part of a family of 1 related entity

  • American Association for the Study of Liver Diseases · exempt

Screen this organization

A dated, signed PDF of the compliance screen for AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES FOUNDATION: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.

A paid feature, included from the $75 plan up. Sign in to download.

Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf

Questions and answers

Who funds AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES FOUNDATION?
AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES FOUNDATION (Virginia) receives grants from 14 organizations whose IRS filings report $1,112,497 to it, the largest being FIDELITY INVESTMENTS CHARITABLE GIFT FUND ($631,712). 5 of them have funded it in more than one year, and 72% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
How many funders does AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES FOUNDATION have?
IRS filings report 14 organizations giving $1,112,497 in grants to AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES FOUNDATION, 5 of which have funded it in more than one year.
Who is the largest funder of AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES FOUNDATION?
FIDELITY INVESTMENTS CHARITABLE GIFT FUND is the largest funder on record, with $631,712 in grants. The full list of funders is on this page.
How can an organization like AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES FOUNDATION find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in Virginia. The funding by cause and by state pages list the largest funders for a given area and how to approach them.

These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2017–2025), and the filings of 14 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing